Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) P/B ratio
As of 25 September 2026, Waters Corporation (WAT) trades at a P/B ratio of 2.8×. Over the past ten years it has ranged from 0.0× (December 2020) to 134× (December 2019); the current reading is higher than 13% of that period. That is below the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 8.8× | (26.71%) |
| FY2024 | 12.0× | (28.67%) |
| FY2023 | 16.9× | (58.93%) |
| FY2022 | 41.1× | (34.17%) |
| FY2021 | 62.4× | (5.68%) |
| FY2020 | 66.2× | — |
| FY2019 | 0.0× | — |
| FY2018 | 9.3× | 32.58% |
| FY2017 | 7.0× | 45.99% |
| FY2016 | 4.8× | (11.04%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.4× | 51.53% |
| Mar 2026 | 1.6× | (81.87%) |
| Dec 2025 | 8.8× | 15.22% |
| Sep 2025 | 7.7× | (20.38%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 134×
Ten-year median
8.4×
Current reading's percentile
13
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| WAT Waters Corporation | 2.8× |
| DGX Quest Diagnostics Incorporated compare | 3.4× |
| A Agilent Technologies, Inc. compare | 6.6× |
| IQV IQVIA Holdings Inc. compare | 7.1× |
| ILMN Illumina, Inc. compare | 14.5× |
| IDXX IDEXX Laboratories, Inc. compare | 25.4× |
| NTRA Natera, Inc. compare | 32.5× |
| MTD Mettler-Toledo International, Inc. compare | 2,372× |
| Diagnostics & Research industry median | 3.1× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement